OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a ...

Opko Health Inc. (NASDAQ:OPK) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. In a report released on May 2, Edward Tenthoff from Piper Sandler reiterated a Buy rating on ...

In this article, we will look at the 13 Best Long-Term Penny Stocks to Buy According to Analysts. What are the Fed’s Plans for 2025? On June 18, Société Générale’s Subadra Rajappa appeared on CNBC to ...

GeneDx Holdings Corp. leverages genomics leadership with robust growth, despite recent stock challenges. Click for more on ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

OPKO Health is witnessing a negative estimate revision trend for 2025. In the past 60 days, the Zacks Consensus Estimate for its loss has widened from 25 cents to 30 cents per share.

Strategic Agreements: OPKO Health has been active on multiple strategic fronts. In March, the company partnered with Entera Bio to develop a once-daily oral GLP-1/glucagon dual agonist tablet ...

OPKO Health, Inc. (NASDAQ:OPK) has been a large holding of mine for years. There is a love/hate relationship with the stock (definitely more heavily leaning towards the hate).

Weston, Massachusetts Wednesday, June 11, 2025, 12:00 Hrs [IST] ...

Review quarterly and annual revenue, net income, and cash flow for OPKO Health Inc (OPK:XNAS) stock through the last fiscal year.

About OPKO Health, Inc. OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its ...